NCT04304482 - ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

June 1, 2023

Study Completion Date

June 30, 2023

Conditions

Rett Syndrome

Interventions

DRUG

ANAVEX2-73 oral liquid

Liquid oral solution

DRUG

Placebo oral liquid

Liquid oral solution

Trial Locations (12)

The Children's Hospital at Westmead, Sydney

Austin Health, Melbourne

Queensland Children's Hospital, Brisbane

Alberta Children's Hospital, Calgary

British Columbia Children's Hospital, Vancouver

Children's Hospital LHSC, London

Holland Bloorview Kids Hospital, Toronto

Royal Hospital for Children, Edinburgh

Evelina London Children's Hospital, London

King's College of London, London

Manchester CGM, St Mary's Hospital, Manchester

Nottingham University Hospital NHS Trust, Nottingham